Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.9B | 2.7B | 2.8B |
Cost of revenue | 1.4B | 1.5B | 1.4B | 1.4B |
Gross profit | 1.4B | 1.4B | 1.3B | 1.3B |
Operating expense | ||||
Research & development | 69M | 59M | 55M | 61M |
Selling general and admin | 273M | 303M | 293M | 268M |
Other operating expenses | 73M | 75M | 68M | 69M |
Operating income | 620M | 603M | 519M | 610M |
Non operating interest income | ||||
Income | 42M | 57M | 67M | 80M |
Expense | 174M | 180M | 179M | 186M |
Other income expense | -17M | -19M | -4M | -8M |
Pretax income | 471M | 461M | 403M | 496M |
Tax provision | 63M | 69M | 50M | 72M |
Net income | 408M | 392M | 353M | 424M |
Basic EPS | 0.5 | 0.5 | 0.4 | 0.5 |
Diluted EPS | 0.5 | 0.5 | 0.4 | 0.5 |
Basic average shares | 608.3K | 616.0K | 623.7K | 632.2K |
Diluted average shares | 609.1K | 617.7K | 624.5K | 633.1K |
EBITDA | 1.0B | 1.0B | 936M | 1.0B |
Net income from continuing op. | 408M | 392M | 353M | 424M |
Minority interests | -56M | -68M | -78M | -71M |
Preferred stock dividends | — | — | — | — |